Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q)
Public ClinicalTrials.gov record NCT02279654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Post-authorization, Non-interventional, Safety Study Study of Patients With Myelodysplastic Syndromes (MDS) Treated With Lenalidomide.
Study identification
- NCT ID
- NCT02279654
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Celgene
- Industry
- Enrollment
- 389 participants
Conditions and interventions
Conditions
Interventions
- Lenalidomide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 16, 2014
- Primary completion
- Mar 28, 2022
- Completion
- Mar 28, 2022
- Last update posted
- Aug 18, 2022
2014 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0001 | Centre City | New Jersey | ZIP CODE | — |
| Local Institution - 0002 | Centre City | New Jersey | ZIP CODE | — |
| Local Institution - Belgium | No City Provided | New Jersey | 00000 | — |
| Local Institution - Denmark | No City Provided | New Jersey | 00000 | — |
| Local Institution - France | No City Provided | New Jersey | 00000 | — |
| Local Institution - Germany | No City Provided | New Jersey | 00000 | — |
| Local Institution - Greece | No City Provided | New Jersey | 00000 | — |
| Local Institution - Italy | No City Provided | New Jersey | 00000 | — |
| Local Institution - Luxembourg | No City Provided | New Jersey | 00000 | — |
| Local Institution - Norway | No City Provided | New Jersey | 00000 | — |
| Local Institution - Spain | No City Provided | New Jersey | 00000 | — |
| Local Institution - Sweden | No City Provided | New Jersey | 00000 | — |
| Local Institution - UK | No City Provided | New Jersey | 00000 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02279654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02279654 live on ClinicalTrials.gov.